The General Election is fast approaching and we want to know how political parties will answer our concerns facing men and families affected by prostate cancer. So here's what to ask when they come knocking – plus the facts to back them up.
We handed in our ‘Don’t delay funding for vital new drugs and treatments’ petition to NHS England, to urge them to reconsider plans for a new spending cap on treatments. We received an incredible 29,006 signatures, but unfortunately the outcome wasn’t what we hoped for.
Thousands of men could be delayed or denied life-saving new drugs under plans to cap spending by NHS England, prompting "serious concern" and an online petition from leading health and care charities.
BLOG: It's been 12 months since we launched our ambitious plan to halve prostate cancer deaths in a decade, and we’ve already taken some huge steps towards our goal. Our chief executive, Angela Culhane, reflects on the progress we’ve made and the exciting work still to come.
BLOG: Today, Prostate Cancer UK and 67 other charities signed a joint letter to the Prime Minister, urging the government to use the Spring Budget to give the NHS the money it needs to end the current crisis. Our Change Delivery Manager, Martin Abrams, explains why the NHS's whole future is at stake.
After today's confirmation that mpMRI scans before a biopsy can radically improve the accuracy of prostate cancer diagnosis, figures reveal that just 32% of eligible men currently have access to the procedure because of a shortage of scanners and qualified staff to use them in the NHS.
BLOG: Today's announcement about mpMRI scans before a biopsy is a game-changer for prostate cancer diagnosis. But without Prostate Cancer UK's funding of a pilot project in 2010 thanks to your donations, this ground-breaking research would never have happened, says Dr Ian Le Guillou.
The Royal College of Surgeons finds 90 per cent of men who had surgery or radiotherapy to cure their prostate cancer on the English NHS rated their care as very good. But Prostate Cancer UK is concerned that over-treatment of men with low-risk localised disease hasn't declined.
Today's Scottish green light for the chemotherapy drug means the same key treatments for advanced prostate cancer are now routinely available to eligible men in all the home nations.
Just 13% of UK's local health commissioners provide adequate care for erectile dysfunction, reveal shocking new figures uncovered by Prostate Cancer UK, leaving thousands of men recovering from prostate cancer treatment struggling with the devastating effects on their health and relationships.